138014 <common-name>Pam2csk4</common-name> <description>Pam2csk4 is an organic compound with the formula C65H126N10O12S. Pam2csk4 belongs to the amino acids, peptides, and analogues, a subclass of carboxylic acids and derivatives within the organic compounds. With an average molecular weight of 1,272 g/mol, Pam2csk4 is a heavy molecule. This compound acts as an agonist for two recorded protein targets, specifically Toll-like receptor 2 (TLR2) and Toll-like receptor 6 (TLR6).</description> <cas>574741-81-4</cas> <pubchem-id>9989023</pubchem-id> <chemical-formula>C65H126N10O12S</chemical-formula> <weight>1271.8</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-04-14T20:55:00Z</created-at> <updated-at type="dateTime">2026-08-23T03:15:27Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id>DB16474</drugbank-id> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CCCCCCCCCCCCCCCC(=O)OCC(CSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O)OC(=O)CCCCCCCCCCCCCCC</moldb-smiles> <moldb-formula>C65H126N10O12S</moldb-formula> <moldb-inchi>InChI=1S/C65H126N10O12S/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-41-58(77)86-48-51(87-59(78)42-28-26-24-22-20-18-16-14-12-10-8-6-4-2)49-88-50-52(70)60(79)75-57(47-76)64(83)73-54(38-30-34-44-67)62(81)71-53(37-29-33-43-66)61(80)72-55(39-31-35-45-68)63(82)74-56(65(84)85)40-32-36-46-69/h51-57,76H,3-50,66-70H2,1-2H3,(H,71,81)(H,72,80)(H,73,83)(H,74,82)(H,75,79)(H,84,85)/t51?,52-,53-,54-,55-,56-,57-/m0/s1</moldb-inchi> <moldb-inchikey>LJUIOEFZFQRWJG-KKIBDXJDSA-N</moldb-inchikey> <moldb-average-mass type="decimal">1271.84</moldb-average-mass> <moldb-mono-mass type="decimal">1270.927740711</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>5.11</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM133907</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-{[2,3-bis(hexadecanoyloxy)propyl]sulfanyl}propanamido]-3-hydroxypropanamido]hexanamido]hexanamido]hexanamido]hexanoic acid</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organic acids and derivatives</superklass> <klass>Carboxylic acids and derivatives</klass> <subklass>Amino acids, peptides, and analogues</subklass> <paper-count type="integer">1030</paper-count> <sync-id>CED0008524</sync-id> <structure-inchikey>LJUIOEFZFQRWJG-KKIBDXJDSA-N</structure-inchikey> <structure-fingerprint>40000000000000000400c00000000e04000011000000000000000002000000000000100002000040000001000000000004000000000000000000000020000000000000000000000400010000000000000020000004000100000000409000000000002020010000000000000000000020000010000000004000000401000000000000000040000020040002000000010080001000000000000000000000001000100000000000000000000000002041000000000048000000000001000004000000000008000000000000308000000000000000000000000000000000000000000000000000008840000000000000010400000000000000000000000080000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAABYAAAAVwAAAIABBgBgAAAAAQMGAGAAAAAC AgYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBgBgAAAAAgIGAGAA AAACAgYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBgBgAAAAAgIG AGAAAAACAgYAYAAAAAICBgAoAAAAAwQIACgAAAADAggAKAAAAAMCBgBgAAAA AgIGAGAAAAADAQYAYAAAAAICEAAgAAAAAgYAYAAAAAICBiA0AAAAAgEEBwBg AAAAAQIGACgAAAADBAgAKAAAAAMCBwBoAAAAAwIBBiA0AAAAAQEEBgBgAAAA AgIIAGAAAAABAQYAKAAAAAMECAAoAAAAAwIHAGgAAAADAgEGIDQAAAABAQQG AGAAAAACAgYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgcAYAAAAAECBgAoAAAA AwQIACgAAAADAgcAaAAAAAMCAQYgNAAAAAEBBAYAYAAAAAICBgBgAAAAAgIG AGAAAAACAgYAYAAAAAICBwBgAAAAAQIGACgAAAADBAgAKAAAAAMCBwBoAAAA AwIBBiA0AAAAAQEEBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBgBgAAAAAgIH AGAAAAABAgYAKAAAAAMECAAoAAAAAwIHAGgAAAADAgEGIDQAAAABAQQGAGAA AAACAgYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgcAYAAAAAECBgAoAAAAAwQI AGgAAAADAQEIACgAAAADAggAKAAAAAMCBgAoAAAAAwQIACgAAAADAgYAYAAA AAICBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgYA YAAAAAICBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBgBgAAAAAgIGAGAAAAAC AgYAYAAAAAICBgBgAAAAAgIGAGAAAAABAwsAAQABAgACAwADBAAEBQAFBgAG BwAHCAAICQAJCgAKCwALDAAMDQANDgAODwAPECgCDxEgERIAEhMAExQAFBUA FRYAFhcAFxgAFxkAGRooAhkbIBscABwdAB0eABwfAB8gKAIfISAhIgAiIwAj JAAkJQAlJgAmJwAiKAAoKSgCKCogKisAKywALC0ALS4ALi8ALzAAKzEAMTIo AjEzIDM0ADQ1ADU2ADY3ADc4ADg5ADQ6ADo7KAI6PCA8PQA9PgA+PwA/QABA QQBBQgA9QwBDRCBDRSgCE0YARkcgR0goAkdJAElKAEpLAEtMAExNAE1OAE5P AE9QAFBRAFFSAFJTAFNUAFRVAFVWAFZXAEIAAAAAFwQAAAAAAAAAFg== </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T04:50:40Z</structure-indexed-at> </compound>